{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:00:41Z","timestamp":1790402441587,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T00:00:00Z","timestamp":1736726400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-024-05993-z","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T11:12:09Z","timestamp":1736766729000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Genetic insight into dissecting the immunophenotypes and inflammatory profiles in the pathogenesis of Sjogren syndrome"],"prefix":"10.1186","volume":"23","author":[{"given":"Jingyi","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shucheng","family":"Si","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxia","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,13]]},"reference":[{"key":"5993_CR1","doi-asserted-by":"publisher","first-page":"16047","DOI":"10.1038\/nrdp.2016.47","volume":"2","author":"P Brito-Zer\u00f3n","year":"2016","unstructured":"Brito-Zer\u00f3n P, Baldini C, Bootsma H, Bowman SJ, Jonsson R, Mariette X, et al. Sj\u00f6gren syndrome. Nat Reviews Disease Primers. 2016;2:16047.","journal-title":"Nat Reviews Disease Primers"},{"issue":"1","key":"5993_CR2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1007\/s10238-021-00728-6","volume":"22","author":"S Negrini","year":"2022","unstructured":"Negrini S, Emmi G, Greco M, Borro M, Sardanelli F, Murdaca G, et al. Sj\u00f6gren\u2019s syndrome: a systemic autoimmune disease. Clin Experimental Med. 2022;22(1):9\u201325.","journal-title":"Clin Experimental Med"},{"issue":"12","key":"5993_CR3","first-page":"2211","volume":"40","author":"V Manfr\u00e8","year":"2022","unstructured":"Manfr\u00e8 V, Chatzis LG, Cafaro G, Fonzetti S, Calvacchi S, Fulvio G, et al. Sj\u00f6gren\u2019s syndrome: one year in review 2022. Clin Exp Rheumatol. 2022;40(12):2211\u201324.","journal-title":"Clin Exp Rheumatol"},{"issue":"20","key":"5993_CR4","first-page":"354","volume":"114","author":"AL Stefanski","year":"2017","unstructured":"Stefanski AL, Tomiak C, Pleyer U, Dietrich T, Burmester GR, D\u00f6rner T. The diagnosis and treatment of Sj\u00f6gren\u2019s syndrome. Deutsches Arzteblatt Int. 2017;114(20):354\u201361.","journal-title":"Deutsches Arzteblatt Int"},{"issue":"9482","key":"5993_CR5","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/S0140-6736(05)66990-5","volume":"366","author":"RI Fox","year":"2005","unstructured":"Fox RI. Sj\u00f6gren\u2019s syndrome. Lancet (London England). 2005;366(9482):321\u201331.","journal-title":"Lancet (London England)"},{"issue":"4","key":"5993_CR6","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.medcli.2022.10.007","volume":"160","author":"P Brito-Zer\u00f3n","year":"2023","unstructured":"Brito-Zer\u00f3n P, Retamozo S, Ramos-Casals M. Sj\u00f6gren syndrome. Med Clin. 2023;160(4):163\u201371.","journal-title":"Med Clin"},{"issue":"6","key":"5993_CR7","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41584-021-00605-2","volume":"17","author":"GM Verstappen","year":"2021","unstructured":"Verstappen GM, Pringle S, Bootsma H, Kroese FGM. Epithelial-immune cell interplay in primary Sj\u00f6gren syndrome salivary gland pathogenesis. Nat Rev Rheumatol. 2021;17(6):333\u201348.","journal-title":"Nat Rev Rheumatol"},{"issue":"10","key":"5993_CR8","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1080\/14728222.2022.2157259","volume":"26","author":"D Ridgewell","year":"2022","unstructured":"Ridgewell D, Thalayasingam N, Ng WF. Sj\u00f6gren\u2019s syndrome: shedding light on emerging and key drug targets. Expert Opin Ther Targets. 2022;26(10):869\u201382.","journal-title":"Expert Opin Ther Targets"},{"issue":"19","key":"5993_CR9","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1001\/jama.2017.17219","volume":"318","author":"CA Emdin","year":"2017","unstructured":"Emdin CA, Khera AV, Kathiresan S. Mendelian Randomization Jama. 2017;318(19):1925\u20136.","journal-title":"Mendelian Randomization Jama"},{"key":"5993_CR10","doi-asserted-by":"crossref","unstructured":"Ference BA, Holmes MV, Smith GD. Using Mendelian Randomization to Improve the Design of Randomized Trials. Cold Spring Harbor perspectives in medicine. 2021;11(7).","DOI":"10.1101\/cshperspect.a040980"},{"issue":"11","key":"5993_CR11","doi-asserted-by":"publisher","first-page":"3253","DOI":"10.1681\/ASN.2016010098","volume":"27","author":"P Sekula","year":"2016","unstructured":"Sekula P, Del Greco MF, Pattaro C, K\u00f6ttgen A. Mendelian randomization as an Approach to assess causality using Observational Data. J Am Soc Nephrology: JASN. 2016;27(11):3253\u201365.","journal-title":"J Am Soc Nephrology: JASN"},{"issue":"16","key":"5993_CR12","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1001\/jama.2021.18236","volume":"326","author":"VW Skrivankova","year":"2021","unstructured":"Skrivankova VW, Richmond RC, Woolf BAR, Yarmolinsky J, Davies NM, Swanson SA, et al. Strengthening the reporting of Observational studies in Epidemiology using mendelian randomization: the STROBE-MR Statement. JAMA. 2021;326(16):1614\u201321.","journal-title":"JAMA"},{"issue":"10","key":"5993_CR13","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41588-020-0684-4","volume":"52","author":"V Orr\u00f9","year":"2020","unstructured":"Orr\u00f9 V, Steri M, Sidore C, Marongiu M, Serra V, Olla S, et al. Complex genetic signatures in immune cells underlie autoimmunity and inform therapy. Nat Genet. 2020;52(10):1036\u201345.","journal-title":"Nat Genet"},{"issue":"1","key":"5993_CR14","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.ajhg.2016.11.007","volume":"100","author":"AV Ahola-Olli","year":"2017","unstructured":"Ahola-Olli AV, W\u00fcrtz P, Havulinna AS, Aalto K, Pitk\u00e4nen N, Lehtim\u00e4ki T, et al. Genome-wide Association Study identifies 27 loci influencing concentrations of circulating cytokines and growth factors. Am J Hum Genet. 2017;100(1):40\u201350.","journal-title":"Am J Hum Genet"},{"issue":"2","key":"5993_CR15","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1002\/oby.23060","volume":"29","author":"M Kalaoja","year":"2021","unstructured":"Kalaoja M, Corbin LJ, Tan VY, Ahola-Olli AV, Havulinna AS, Santalahti K, et al. The role of inflammatory cytokines as intermediates in the pathway from increased adiposity to Disease. Obes (Silver Spring). 2021;29(2):428\u201337.","journal-title":"Obes (Silver Spring)"},{"issue":"9","key":"5993_CR16","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","volume":"24","author":"JH Zhao","year":"2023","unstructured":"Zhao JH, Stacey D, Eriksson N, Macdonald-Dunlop E, Hedman \u00c5K, Kalnapenkis A, et al. Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. Nat Immunol. 2023;24(9):1540\u201351.","journal-title":"Nat Immunol"},{"issue":"7944","key":"5993_CR17","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","volume":"613","author":"MI Kurki","year":"2023","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner KM, et al. FinnGen provides genetic insights from a well-phenotyped isolated population. Nature. 2023;613(7944):508\u201318.","journal-title":"Nature"},{"issue":"7","key":"5993_CR18","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s41588-021-00870-7","volume":"53","author":"J Mbatchou","year":"2021","unstructured":"Mbatchou J, Barnard L, Backman J, Marcketta A, Kosmicki JA, Ziyatdinov A, et al. Computationally efficient whole-genome regression for quantitative and binary traits. Nat Genet. 2021;53(7):1097\u2013103.","journal-title":"Nat Genet"},{"issue":"3","key":"5993_CR19","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/ije\/dyr036","volume":"40","author":"S Burgess","year":"2011","unstructured":"Burgess S, Thompson SG. Avoiding bias from weak instruments in mendelian randomization studies. Int J Epidemiol. 2011;40(3):755\u201364.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"5993_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1002\/gepi.22295","volume":"44","author":"EAW Slob","year":"2020","unstructured":"Slob EAW, Burgess S. A comparison of robust mendelian randomization methods using summary data. Genet Epidemiol. 2020;44(4):313\u201329.","journal-title":"Genet Epidemiol"},{"issue":"5","key":"5993_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","volume":"32","author":"S Burgess","year":"2017","unstructured":"Burgess S, Thompson SG. Interpreting findings from mendelian randomization using the MR-Egger method. Eur J Epidemiol. 2017;32(5):377\u201389.","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"5993_CR22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in mendelian randomization with some Invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40(4):304\u201314.","journal-title":"Genet Epidemiol"},{"issue":"21","key":"5993_CR23","doi-asserted-by":"publisher","first-page":"2926","DOI":"10.1002\/sim.6522","volume":"34","author":"MF Greco","year":"2015","unstructured":"Greco MF, Minelli C, Sheehan NA, Thompson JR. Detecting pleiotropy in mendelian randomisation studies with summary data and a continuous outcome. Stat Med. 2015;34(21):2926\u201340.","journal-title":"Stat Med"},{"issue":"1","key":"5993_CR24","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","volume":"28","author":"S Burgess","year":"2017","unstructured":"Burgess S, Bowden J, Fall T, Ingelsson E, Thompson SG. Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants. Epidemiol (Cambridge Mass). 2017;28(1):30\u201342.","journal-title":"Epidemiol (Cambridge Mass)"},{"issue":"5","key":"5993_CR25","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","volume":"50","author":"M Verbanck","year":"2018","unstructured":"Verbanck M, Chen CY, Neale B, Do R. Detection of widespread horizontal pleiotropy in causal relationships inferred from mendelian randomization between complex traits and diseases. Nat Genet. 2018;50(5):693\u20138.","journal-title":"Nat Genet"},{"key":"5993_CR26","unstructured":"undefined u, undefined u, undefined u, undefined u, undefined u, undefined u, et al. Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. 2014;10."},{"key":"5993_CR27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1146\/annurev.psych.58.110405.085542","volume":"58","author":"DP MacKinnon","year":"2007","unstructured":"MacKinnon DP, Fairchild AJ, Fritz MS. Mediation analysis. Annu Rev Psychol. 2007;58:593\u2013614.","journal-title":"Annu Rev Psychol"},{"issue":"5","key":"5993_CR28","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1007\/s10654-021-00757-1","volume":"36","author":"AR Carter","year":"2021","unstructured":"Carter AR, Sanderson E, Hammerton G, Richmond RC, Davey Smith G, Heron J, et al. Mendelian randomisation for mediation analysis: current methods and challenges for implementation. Eur J Epidemiol. 2021;36(5):465\u201378.","journal-title":"Eur J Epidemiol"},{"issue":"6\u20137","key":"5993_CR29","first-page":"647","volume":"31","author":"S Weller","year":"2015","unstructured":"Weller S, Descatoire M. IgM\u2009+\u2009IgD\u2009+\u2009CD27\u2009+\u2009B cells in human: an essential role in the protection against encapsulated bacteria. Med Sciences: M\/S. 2015;31(6\u20137):647\u201353.","journal-title":"Med Sciences: M\/S"},{"key":"5993_CR30","doi-asserted-by":"publisher","first-page":"684999","DOI":"10.3389\/fimmu.2021.684999","volume":"12","author":"W Du","year":"2021","unstructured":"Du W, Han M, Zhu X, Xiao F, Huang E, Che N, et al. The multiple roles of B cells in the pathogenesis of Sj\u00f6gren\u2019s syndrome. Front Immunol. 2021;12:684999.","journal-title":"Front Immunol"},{"issue":"3","key":"5993_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrrheum.2018.1","volume":"14","author":"G Nocturne","year":"2018","unstructured":"Nocturne G, Mariette X. B cells in the pathogenesis of primary Sj\u00f6gren syndrome. Nat Rev Rheumatol. 2018;14(3):133\u201345.","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"5993_CR32","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/eos.12536","volume":"126","author":"R Jonsson","year":"2018","unstructured":"Jonsson R, Brokstad KA, Jonsson MV, Delaleu N, Skarstein K. Current concepts on Sj\u00f6gren\u2019s syndrome - classification criteria and biomarkers. Eur J Oral Sci. 2018;126(1):37\u201348.","journal-title":"Eur J Oral Sci"},{"issue":"2","key":"5993_CR33","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1182\/blood-2010-07-294249","volume":"117","author":"Y Iwata","year":"2011","unstructured":"Iwata Y, Matsushita T, Horikawa M, Dilillo DJ, Yanaba K, Venturi GM, et al. Characterization of a rare IL-10-competent B-cell subset in humans that parallels mouse regulatory B10 cells. Blood. 2011;117(2):530\u201341.","journal-title":"Blood"},{"issue":"1","key":"5993_CR34","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jdsr.2019.09.006","volume":"55","author":"HM Ibrahem","year":"2019","unstructured":"Ibrahem HM. B cell dysregulation in primary Sj\u00f6gren\u2019s syndrome: a review. Japanese Dent Sci Rev. 2019;55(1):139\u201344.","journal-title":"Japanese Dent Sci Rev"},{"issue":"6","key":"5993_CR35","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/art.42422","volume":"75","author":"TD Steinmetz","year":"2023","unstructured":"Steinmetz TD, Verstappen GM, Schulz SR, de Wolff L, Wilbrink R, Visser A, et al. Association of circulating antibody-secreting cell Maturity with Disease features in primary Sj\u00f6gren\u2019s syndrome. Arthritis Rheumatol. 2023;75(6):973\u201383.","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"5993_CR36","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1007\/s10067-020-04996-7","volume":"39","author":"L Bergantini","year":"2020","unstructured":"Bergantini L, d\u2019Alessandro M, Cameli P, Vietri L, Vagaggini C, Perrone A, et al. Effects of Rituximab therapy on B cell differentiation and depletion. Clin Rheumatol. 2020;39(5):1415\u201321.","journal-title":"Clin Rheumatol"},{"issue":"1","key":"5993_CR37","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2019-216114","volume":"79","author":"M Ramos-Casals","year":"2020","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Bombardieri S, Bootsma H, De Vita S, D\u00f6rner T, et al. EULAR recommendations for the management of Sj\u00f6gren\u2019s syndrome with topical and systemic therapies. Ann Rheum Dis. 2020;79(1):3\u201318.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"5993_CR38","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00281-019-00741-8","volume":"41","author":"L G\u00f6schl","year":"2019","unstructured":"G\u00f6schl L, Scheinecker C, Bonelli M. Treg cells in autoimmunity: from identification to Treg-based therapies. Semin Immunopathol. 2019;41(3):301\u201314.","journal-title":"Semin Immunopathol"},{"issue":"7","key":"5993_CR39","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nri2785","volume":"10","author":"S Sakaguchi","year":"2010","unstructured":"Sakaguchi S, Miyara M, Costantino CM, Hafler DA. FOXP3\u2009+\u2009regulatory T cells in the human immune system. Nat Rev Immunol. 2010;10(7):490\u2013500.","journal-title":"Nat Rev Immunol"},{"key":"5993_CR40","doi-asserted-by":"crossref","unstructured":"Blinova VG, Vasilyev VI, Rodionova EB, Zhdanov DD. The Role of Regulatory T Cells in the Onset and Progression of Primary Sj\u00f6gren\u2019s Syndrome. Cells. 2023;12(10).","DOI":"10.3390\/cells12101359"},{"key":"5993_CR41","doi-asserted-by":"publisher","first-page":"243723","DOI":"10.1155\/2015\/243723","volume":"2015","author":"A Alunno","year":"2015","unstructured":"Alunno A, Carubbi F, Bistoni O, Caterbi S, Bartoloni E, Mirabelli G, et al. T Regulatory and T Helper 17 cells in primary Sj\u00f6gren\u2019s syndrome: facts and perspectives. Mediat Inflamm. 2015;2015:243723.","journal-title":"Mediat Inflamm"},{"key":"5993_CR42","doi-asserted-by":"publisher","first-page":"1127417","DOI":"10.3389\/fimmu.2023.1127417","volume":"14","author":"Q Zhan","year":"2023","unstructured":"Zhan Q, Zhang J, Lin Y, Chen W, Fan X, Zhang D. Pathogenesis and treatment of Sjogren\u2019s syndrome: review and update. Front Immunol. 2023;14:1127417.","journal-title":"Front Immunol"},{"key":"5993_CR43","doi-asserted-by":"crossref","unstructured":"Matsui K, Sano HT. Helper 17 Cells in Primary Sj\u00f6gren\u2019s Syndrome. J Clin Med. 2017;6(7).","DOI":"10.3390\/jcm6070065"},{"key":"5993_CR44","doi-asserted-by":"crossref","unstructured":"R\u00edos-R\u00edos WJ, Sosa-Luis SA, Torres-Aguilar H. T Cells Subsets in the Immunopathology and Treatment of Sjogren\u2019s Syndrome. Biomolecules. 2020;10(11).","DOI":"10.3390\/biom10111539"},{"issue":"5","key":"5993_CR45","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1097\/00002281-199110000-00004","volume":"3","author":"JD Mountz","year":"1991","unstructured":"Mountz JD, Gause WC, Jonsson R. Murine models for systemic lupus erythematosus and Sj\u00f6gren\u2019s syndrome. Curr Opin Rheumatol. 1991;3(5):738\u201356.","journal-title":"Curr Opin Rheumatol"},{"issue":"2","key":"5993_CR46","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/030097499442577","volume":"28","author":"YT Konttinen","year":"1999","unstructured":"Konttinen YT, Kemppinen P, Koski H, Li TF, Jumppanen M, Hietanen J, et al. T(H)1 cytokines are produced in labial salivary glands in Sj\u00f6gren\u2019s syndrome, but also in healthy individuals. Scand J Rheumatol. 1999;28(2):106\u201312.","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"5993_CR47","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/jop.13070","volume":"49","author":"LA Moreno-Quispe","year":"2020","unstructured":"Moreno-Quispe LA, Serrano J, Virto L, Sanz M, Ram\u00edrez L, Fern\u00e1ndez-Castro M, et al. Association of salivary inflammatory biomarkers with primary Sj\u00f6gren\u2019s syndrome. J Oral Pathol Med. 2020;49(9):940\u20137.","journal-title":"J Oral Pathol Med"},{"issue":"7","key":"5993_CR48","doi-asserted-by":"publisher","first-page":"2300","DOI":"10.1002\/art.21945","volume":"54","author":"MV Jonsson","year":"2006","unstructured":"Jonsson MV, Delaleu N, Brokstad KA, Berggreen E, Skarstein K. Impaired salivary gland function in NOD mice: association with changes in cytokine profile but not with histopathologic changes in the salivary gland. Arthritis Rheum. 2006;54(7):2300\u20135.","journal-title":"Arthritis Rheum"},{"key":"5993_CR49","doi-asserted-by":"publisher","first-page":"107709","DOI":"10.1016\/j.pharmthera.2020.107709","volume":"219","author":"T Tang","year":"2021","unstructured":"Tang T, Cheng X, Truong B, Sun L, Yang X, Wang H. Molecular basis and therapeutic implications of CD40\/CD40L immune checkpoint. Pharmacol Ther. 2021;219:107709.","journal-title":"Pharmacol Ther"},{"issue":"6","key":"5993_CR50","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.trsl.2006.07.003","volume":"148","author":"H Nakamura","year":"2006","unstructured":"Nakamura H, Kawakami A, Eguchi K. Mechanisms of autoantibody production and the relationship between autoantibodies and the clinical manifestations in Sj\u00f6gren\u2019s syndrome. Transl Res. 2006;148(6):281\u20138.","journal-title":"Transl Res"},{"issue":"6","key":"5993_CR51","first-page":"1356","volume":"41","author":"F Brignole","year":"2000","unstructured":"Brignole F, Pisella PJ, Goldschild M, De Saint Jean M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci. 2000;41(6):1356\u201363.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"8","key":"5993_CR52","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s41584-024-01135-3","volume":"20","author":"C Baldini","year":"2024","unstructured":"Baldini C, Fulvio G, La Rocca G, Ferro F. Update on the pathophysiology and treatment of primary Sj\u00f6gren syndrome. Nat Rev Rheumatol. 2024;20(8):473\u201391.","journal-title":"Nat Rev Rheumatol"},{"issue":"11","key":"5993_CR53","doi-asserted-by":"publisher","first-page":"e2241451","DOI":"10.1001\/jamanetworkopen.2022.41451","volume":"5","author":"J He","year":"2022","unstructured":"He J, Chen J, Miao M, Zhang R, Cheng G, Wang Y, et al. Efficacy and safety of low-dose interleukin 2 for primary Sj\u00f6gren Syndrome: a Randomized Clinical Trial. JAMA Netw Open. 2022;5(11):e2241451.","journal-title":"JAMA Netw Open"},{"issue":"10320","key":"5993_CR54","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0140-6736(21)02251-0","volume":"399","author":"SJ Bowman","year":"2022","unstructured":"Bowman SJ, Fox R, D\u00f6rner T, Mariette X, Papas A, Grader-Beck T, et al. Safety and efficacy of subcutaneous ianalumab (VAY736) in patients with primary Sj\u00f6gren\u2019s syndrome: a randomised, double-blind, placebo-controlled, phase 2b dose-finding trial. Lancet. 2022;399(10320):161\u201371.","journal-title":"Lancet"},{"issue":"5","key":"5993_CR55","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1002\/art.42772","volume":"76","author":"E Pontarini","year":"2024","unstructured":"Pontarini E, Sciacca E, Chowdhury F, Grigoriadou S, Rivellese F, Murray-Brown WJ, et al. Serum and tissue biomarkers Associated with Composite of relevant endpoints for Sj\u00f6gren Syndrome (CRESS) and Sj\u00f6gren Tool for assessing response (STAR) to B cell-targeted therapy in the trial of Anti-B cell therapy in patients with primary Sj\u00f6gren Syndrome (TRACTISS). Arthritis Rheumatol. 2024;76(5):763\u201376.","journal-title":"Arthritis Rheumatol"},{"key":"5993_CR56","doi-asserted-by":"crossref","unstructured":"Mariette X, Barone F, Baldini C, Bootsma H, Clark KL, De Vita S et al. A randomized, phase II study of sequential belimumab and rituximab in primary Sj\u00f6gren\u2019s syndrome. JCI Insight. 2022;7(23).","DOI":"10.1172\/jci.insight.163030"},{"issue":"10452","key":"5993_CR57","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/S0140-6736(24)01211-X","volume":"404","author":"BA Fisher","year":"2024","unstructured":"Fisher BA, Mariette X, Papas A, Grader-Beck T, Bootsma H, Ng WF, et al. Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sj\u00f6gren\u2019s disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study. Lancet. 2024;404(10452):540\u201353.","journal-title":"Lancet"},{"issue":"5","key":"5993_CR58","doi-asserted-by":"publisher","first-page":"2066","DOI":"10.1093\/rheumatology\/kez142","volume":"60","author":"RI Fox","year":"2021","unstructured":"Fox RI, Fox CM, Gottenberg JE, D\u00f6rner T. Treatment of Sj\u00f6gren\u2019s syndrome: current therapy and future directions. Rheumatology (Oxford). 2021;60(5):2066\u201374.","journal-title":"Rheumatology (Oxford)"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05993-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-05993-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-05993-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T11:29:52Z","timestamp":1736767792000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-05993-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,13]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5993"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-05993-z","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,13]]},"assertion":[{"value":"19 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"56"}}